Grants for Public and State controlled institutions of higher education - Science and Technology

This grant provides funding to support the development and enhancement of research infrastructure in computer and information science, specifically aimed at fostering diverse research communities across various educational and non-profit organizations.

This funding opportunity provides financial support to rural libraries in Oregon to create community-focused humanities events that explore themes related to public life and community engagement.

The General Operating Support (GOS) Grants, offered by the Illinois Arts Council Agency (IACA), aim to bolster established not-for-profit organizations that deliver arts programming to their communities. This initiative directly aligns with the IACA's mission to support and strengthen the arts in Illinois. The grant provides financial assistance ranging from $1,000 to $10,000 for activities occurring between November 1, 2024, and August 31, 2025. Eligible entities include registered 501(c)(3) not-for-profit organizations, branches of government, charitable trusts, institutions of higher education, religious organizations, and school affiliate organizations, all of whom must be in good standing with the state and meet specific operational and application criteria. The primary beneficiaries of this grant are not-for-profit arts organizations and, by extension, the diverse communities they serve across all counties in Illinois. The IACA's strategic priorities for this initiative are deeply rooted in equity and outreach. The program specifically focuses on under-resourced communities, including rural areas, high-poverty regions, BIPOC (Black, Indigenous, and People of Color) groups, and individuals with disabilities. This targeted approach seeks to ensure that state support reaches a broader and more equitable demographic of Illinois communities. The initiative's core aims include analyzing the demographic distribution of past awards, engaging constituents for feedback on their needs and experiences, identifying areas for improvement in the IACA's funding approach regarding equity, and recommending actionable steps to achieve greater grant-making equity. These objectives are designed to build an evidence base that can be used to advocate for the resources necessary to expand state support to a wider array of Illinois communities. Expected outcomes and measurable results revolve around a more equitable distribution of arts funding and increased access to arts programming for under-resourced communities. The IACA anticipates that by addressing equity strengths and weaknesses and implementing recommended actions, they will successfully reach more diverse communities. Allowable expenses cover a wide range of operational costs, from artist fees and salaries to facilities, supplies, technology, marketing, and general administrative overhead, ensuring that organizations can effectively implement their programs and achieve their community impact goals.

This funding opportunity provides financial support for research and development of innovative rehabilitation technologies aimed at improving the independence and quality of life for children with orthopedic disabilities.

This funding opportunity provides financial support to organizations working to prevent Russia from acquiring and using chemical and biological weapons through enhanced security measures, training, and international collaboration.

This funding opportunity supports collaborative research between U.S. and Danish organizations to develop innovative mooring and anchoring technologies for floating offshore wind energy, with a focus on reducing costs and improving performance while engaging minority-serving institutions and considering environmental impacts.

This Broad Agency Announcement (BAA) for the Foundational Science Research Unit (FSRU) of the U.S. Army Research Institute for the Behavioral and Social Sciences (ARI) solicits new proposals for its fiscal year 2025 program of basic research in behavioral science. It is issued under the provisions of paragraph 6.102(d) (2) and 35.016 of the Federal Acquisition Regulation (FAR), which provides for the acquisition of basic and applied research and that part of development not related to the development of a specific system or hardware procurement through the competitive selection of proposals and 10 U.S.C. 4001, 10 U.S.C. 4021, and 10 U.S.C. 4022.To meet the operational objectives of the U.S. Army over the next two decades, the Army must improve its capability to acquire, develop, employ, and retain Soldiers and leaders who can individually and as part of a group: Prepare for and adapt quickly to dynamic missions, unpredictable operational environments, and a wide spectrum of contexts; Effectively function autonomously and as part of larger systems in complex, information-rich environments; Perform in extended, hybrid, and continuous operations; Interact and collaborate effectively in joint-service and multi-national operations.ARI requests proposals to conduct basic research that will provide a scientific foundation to support these broad capabilities.The Basic Research program focuses on three strategic areas for advancing personnel science.1. Science of Measurement of Individuals and Collectives: Advanced psychometric theory for deriving valid measurements from complex assessments and continuous streams of data2. Understanding Multilevel and Organizational Dynamics: Multilevel theory and methods for understanding dynamic restructuring, coordination, and composition processes in teams and complex organizations3. Formal/Informal Learning and Development: Holistic models of individual and collective learning and development across work settings and contexts throughout the career spanTo be eligible for an award under this announcement, a potential awardee must meet certain minimum standards pertaining to financial resources and responsibility, ability to comply with the performance schedule, past performance, integrity, experience, technical capabilities, operational controls, and facilities. In accordance with Federal statutes, regulations, and Department of Defense and Army policies, no person on grounds of race, color, age, sex, national origin, or disability shall be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any program or activity receiving financial assistance from the Army.Response Dates (Submissions):White Paper submissions must be received by: 5:00 PM/1700 Eastern Standard Time (EST) on 1 March 2024Proposal submissions must be received by: 5:00 PM/1700 Eastern Daylight Time (EDT) on 1 July 20242024 Response Dates (Questions):Questions regarding White Papers must be submitted in writing to [email protected] by: 5:00 PM/1700 Eastern Standard Time (EST) on 14 February 2024Questions regarding Proposals must be submitted in writing to [email protected] by: 5:00 PM/1700 Eastern Daylight Time (EDT) on 15 June 2024

This grant provides funding for U.S. institutions to develop and enhance advanced computing resources that support scientific and engineering research, particularly for underserved communities.

This funding opportunity provides financial support for projects that install and maintain technologies to intercept and remove marine debris, benefiting coastal habitats and marine resources.

This funding opportunity seeks innovative research proposals from universities, businesses, and nonprofits to develop advanced AI technologies that can significantly accelerate mathematical progress and enhance national competitiveness.

This program provides ARO scientific staff with opportunities to conduct collaborative basic research with external institutions, enhancing their professional skills while advancing knowledge in various scientific fields.

This funding opportunity provides operational support for the National Biocontainment Laboratories at Boston University and the University of Texas Medical Branch, enabling critical research on hazardous biological agents and biodefense initiatives.

The OHSU Knight Cancer Institute's Community Partnership Program (CPP) is designed to cultivate sustainable collaborations with Oregon communities to address identified cancer needs. The program's mission is to partner with these communities as allies in the Knight Cancer Institute's goal of ending cancer. This aligns with a broader strategic priority to enhance community-OHSU collaboration on local cancer issues and disparities, fostering long-term sustainability of local efforts. The CPP targets various Oregon community groups, including organizations, schools, government bodies, health/medical clinics, health systems, and businesses. A key focus is on proposals that address cancer-related health disparities and increase equity for historically disadvantaged and/or marginalized Oregon communities. Organizations led by and/or committed to serving these populations are highly encouraged to apply, underscoring the program's commitment to equitable cancer outcomes. The program's priorities revolve around supporting communities in identifying and addressing pressing cancer-related needs, enhancing collaboration, and building community skills for sustainable long-term efforts. This is operationalized through three grant tiers. Tier 1, "Define Need," focuses on developing local action plans through needs assessments or committee formation. Tier 2, "Develop and Pilot," supports the development and piloting of programs to address priority cancer issues or disparities. Tier 3, "Evaluate and Sustain," aims to evaluate existing approaches and establish sustainability strategies. Expected outcomes include communities effectively identifying their most pressing cancer-related needs, increased collaboration between OHSU and local communities, and enhanced capacity within communities to sustain efforts addressing local cancer issues. Measurable results would be tied to the specific objectives of each tier, such as the completion of community cancer needs assessments (Tier 1), the successful piloting of new programs (Tier 2), and the evaluation and sustained implementation of effective approaches (Tier 3). The overall impact goal is to collectively work towards ending cancer as communities know it, with a strong emphasis on reducing health disparities.

This funding opportunity supports U.S. institutions and non-profits in organizing conferences and workshops that advance research, education, and community engagement in the mathematical sciences, with a focus on inclusivity and diversity.

The DoD Kidney Cancer, Idea Development Award is a funding opportunity aimed at supporting innovative, high-impact kidney cancer research projects, with a focus on scientific rationale, preliminary data, innovation, and potential impact, and encourages collaborations among academia, industry, military services, and other federal agencies, with a budget not exceeding $800,000 for individual projects and $1.2M for partnered projects.

The FY24 PCRP Data Science Award mechanism supports research where quantitative and analytical approaches, processes, and/or systems are developed and/or used to obtain knowledge and insight from large and/or complex sets of prostate cancer data. If successful, the studies will enable progress toward addressing one or more of the FY24 PCRP Overarching Challenges. It is expected that any resources, tools, or computational processes generated by this award will be openly shared with the prostate cancer research and patient community. This mechanism is intended to fund research built upon the logic, concepts, and methods of one or more of the following research areas as they pertain to prostate cancer: Computational biology Bioinformatics Artificial intelligence and machine learning Epidemiology Analysis of omics data Medical imaging Digital pathology Analysis of other clinically annotated datasetsApplications may combine diverse data types for integrative analysis to increase knowledge about prostate cancer with respect to the FY24 PCRP Overarching Challenges. Applications that propose to develop resources or tools that allow research, clinical care, and patient community access to standardized and harmonized datasets for real-time clinical care applications are of particular interest; however, this award must not be used to support the development of new datasets. Studies utilizing data derived from large patient studies that include long-term health records or repositories with well-annotated and high-quality biospecimens are encouraged.Key Features: Research Approach: Applications may propose development of a new data-science-driven tool or apply an existing tool or method to gather and analyze information from large datasets with the intent of advancing prostate cancer research and patient care relative to the FY24 PCRP Overarching Challenges. Inclusion of preliminary data to support the scientific rationale and feasibility of research approaches is strongly encouraged, but not required. Any preliminary data provided should be from the laboratory of the Principal Investigator(s) (PI[s]) or member(s) of the collaborating team. Applicants are encouraged to include plans for rigorous validation, benchmarking, comparisons, and/or evaluations to assess the quality or utility of the tools and/or approaches that will be used or developed under this award. Any datasets used in the study design must be from established, retrospective databases and be sufficient in size to provide appropriate analytical and statistical power. Prospective recruitment of human subjects and/or clinical trials is not allowed under this funding opportunity. Applicants are expected to provide documentation demonstrating access to the appropriate datasets and/or patient samples in numbers sufficient to achieve robust results. Impact: Applications are required to clearly communicate how the proposed quantitative and/or analytical approaches, processes, and/or systems will address and provide a solution to one or more of the FY24 PCRP Overarching Challenges. The potential impact of the research, both short- and long-term, should be clearly described, including how the anticipated outcomes or products are distinct from existing research efforts in this area and/or how they will significantly outperform current approaches in this area. High-impact research will, if successful, significantly advance prostate cancer research and/or patient care. Data and Resource Sharing Plan: It is expected that any resources, tools, and computational processes that are developed under this award will be openly shared with the prostate cancer research and patient community. Plans must be provided for how additional data generated by future studies will be incorporated to further inform and refine the data science tools, processes, and/or methods generated and/or used in this study. Refer to the CDMRPs Policy on Data Resource Sharing located on the Electronic Biomedical Research Application Portal (eBRAP) Funding Opportunities Forms web page https://ebrap.org/eBRAP/public/Program.htm for more information about the CDMRPs expectations for making data and research resources publicly available.Partnering PI Option: The FY24 PCRP Data Science Award encourages applications that include meaningful and productive collaborations between investigators. The PIs may have expertise in similar or disparate scientific disciplines, but each PI is expected to bring distinct contributions to the application; collaborations between data scientists and clinicians are highly encouraged. The Partnering PI Option is structured to accommodate two PIs. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI will be identified as a Partnering PI. Both PIs should contribute significantly to the development and execution of the proposed research project, including the Project Narrative, Statement of Work (SOW) and other required components. If recommended for funding, each PI will be named on separate awards to the recipient organization. Each award will be subject to separate reporting, regulatory, and administrative requirements. For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (http://www.nature.com/ nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies.Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 PCRP Data Science Award should not exceed $1.0M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $11.2M to fund approximately seven Data Science Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity provides financial support to U.S. colleges and universities for purchasing major research equipment to enhance defense-related research and education in science, technology, engineering, and mathematics (STEM).

The Arizona Water Protection Fund (AWPF) is a competitive state grant program that provides funding to interested parties for the development and implementation of measures to protect water of sufficient quality and quantity to maintain, enhance, and restore river and riparian resources throughout Arizona (including projects that benefit fish and wildlife that are dependent on these important resources), and measures to increase water availability and supply. Financial Notes: Matching funds are not required to be eligible for AWPF funding; however, projects that do include matching funds typically receive higher consideration.   Administrative costs must be limited to a maximum of 5% of the total AWPF project funds requested.  Subcontractors or consultants working on your project must also conform to the 5% administrative cost limit if you are paying them out of AWPF funds.   Payments are made on a cost reimbursement basis.  Appropriate documentation (e.g., receipts, invoices, reports, data, and photographs) will be required in order to receive reimbursement.   Adequate accounting practices and record keeping will be required.

The DARPA Defense Sciences Office grant is aimed at fostering scientific discovery and innovation, anticipating future technological advancements, and understanding global changes to maintain a strategic advantage for the Department of Defense.

The Pennsylvania Department of Agriculture is inviting applications for agricultural research grants for projects to be conducted from July 1, 2024, to June 30, 2026. The projects should address various critical areas such as pest infestation impacts, Chesapeake Bay farm management practices, pollinator protection, food action plans, urban agriculture, energy in agriculture, animal health, and robotic technology in farming. Funding is contingent upon the 2024-2025 budget appropriations, and the deadline for application submission is June 7, 2024. The department will evaluate the proposals based on a 100-point scale considering project needs, research outcomes, methodology, evaluation and replicability, industry support, and research team diversity.